1Shoskes DA. Use of antibiotics in chronic prostatitis syndromes. Can J Urol 2001; 8(Suppll): 24-28.
2Krieger JN, Riley DE. Bacteria in the chronic prostatitis- chronic pelvic pain syndrome: molecular approaches to critical research questions. J Uro12002; 167(6): 2574- 2583.
3吴阶平.实用泌尿外科.北京:人民军医出版社,2000:27-28.165-166.
4Propert KJ, McNaughton-Collins M, Leiby BE, et al. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pare syndrome: the National Institutes of Health Chronic Prostatitis Cohort study. J Uro12006; 175(2): 619-623.
5Pliquett U. Mechanistic studies of molecular transdermal transport due to skin electroporation [ J ]. Adv Drug Deliv Rev, 1999,35 (1) :41 -60.
6Tang H, Wang CC, Blanksehtein D, et al. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdennal drug transport I J ]. Pharm Res,2002,19 ( 8 ) : 1160 - 1169.
7Sieg A, Wascotte V. Diagnostic and therapeutic applications of iontophoresis[ J]. Drug Target ,2009,17 ( 9 ) :690 - 700.
8Doan N,Reher P,Meghji S,et al. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes [ J ]. Oral Maxillofac Surg, 1999,57 (4) :409 - 419.
9Ng KY, Liu Y. Therapeutic ultrasound:its application in drug delivery [ J ]. Med Res Rev,2002,22 ( 2 ) :204 - 223.
10Litwin MS,McNaughton CM,Fowler FJ,et al.The national institutes of health chronic prostatitis symptom index:development and validation of a new outcome measure[J].J Urol,1999,162(2):369.
